Forum Posts

broro75
May 13, 2022
In General Discussions
The American Medical Association (AMA) is issuing the CPT code update to ensure electronic systems across the U.S. health care system are ready in advance for the potential FDA authorization. The AMA announced an editorial update to Current Procedural Terminology (CPT), including recently assigned provisional CPT codes for COVID-19 booster candidates from Pfizer and Sanofi-GlaxoSmithKline. Indeed, the CPT Editorial Panel has approved the addition of 35 Category I codes, including three Category I codes to report the Sanofi Pasteur booster vaccine code and its associated administration code, and the Pfizer booster code. The Sanofi-GSK booster candidate is proposed for use in persons age 18 and older who have completed a COVID-19 vaccine primary series. In contrast, the Pfizer booster candidate is suggested for use in children ages 5 to 11 who have completed a COVID-19 vaccine primary series. The Administration code for Pfizer booster candidate is : 0074A: Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV- 2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation; booster dose The product and administration codes for Sanofi-GSK booster candidate are: 91310: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, monovalent, preservative free, 5 mcg/0.5 mL dosage, adjuvant AS03 emulsion, for intramuscular use. 0104A: Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, monovalent, preservative free, 5 mcg/0.5 mL dosage, adjuvant AS03 emulsion, booster dose. To know more about all the new vaccine-specific CPT codes, click HERE Who needs More Vitamin D Risk Adjustment documentation Challenge Product and services (Volume versus Quality) About chronic conditions Promote Valid Documentation Tips and tricks to know about Documenting for Medicare Advantage Patients Is it worth having a medical coder?
Newly assigned provisional CPT codes for COVID-19 booster candidates content media
0
0
44
broro75
Aug 06, 2021
In General Discussions
The CPT Editorial Panel has updated the Current Procedural Terminology (CPT®) code set to include a new administration code that is unique to a potential third dose of the current COVID-19 vaccine offered by Pfizer. The provisional CPT code will be valid for use on the condition that a third dose shot of the Pfizer COVID-19 vaccine receives regulatory approval or authorization from the U.S. Food and Drug Administration (FDA). The FDA and the CDC have analyzed data indicating that, at this time, individuals do not need to exceed the standard two doses authorized for Pfizer’s COVID-19 vaccine. These federal health agencies will continue to review emerging evidence on a potential third dose of the Pfizer COVID-19 vaccine. The vaccine administration CPT code and long descriptor assigned to the third dose of the current Pfizer COVID-19 vaccine is: 0003A Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, diluent reconstituted; third dose To learn more, click HERE Be the first one receiving emails from us about our Services, quizzes, and Articles published on our Blog and Forum Click HERE Make a positive impact on your medical practice's RAF score. Claim access to the Perfect Recipe Today while saving up to 50% Click HERE Obtain almost for Free The Framework, the step-by-step process to Improve your Medical Practice's RAF score Click HERE Cellphone Card to call Families and Friends Abroad Click Enjoy Relaxing Music for Stress Relief, Sleep, Meditation Click Our BLOG
Code  for potential third dose of Pfizer vaccine content media
0
0
95
broro75
Jun 18, 2021
In General Discussions
The CPT Editorial Panel has updated the Current Procedural Terminology (CPT) code set to include vaccine and administration codes that are unique to the COVID-19 vaccine candidate under development by Novavax Inc. But we need to wait for the Novavax COVID-19 vaccine to receive approval or emergency use authorization from the U.S. Food and Drug Administration (FDA) before the provisional CPT codes will be effective for use. Indeed, Novavax said it plans to file for authorization with the FDA in the third quarter. The Novavax COVID-19 vaccine joins other COVID-19 vaccines from AstraZeneca, Janssen (Johnson & Johnson), Moderna, and Pfizer, which will avoid possible supply disruptions. So far, the CPT Editorial Panel has approved a total of 14 Category I codes for COVID-19 immunizations. These CPT codes are unique for each of the coronavirus vaccines, as well as administration codes unique to each such vaccine and dose. To have more information about these vaccine-CPT codes such as Short, medium, and long descriptors, click on the following link: AMA website We all know that Invalid risk adjustment documentation has negative feedback on reimbursement. What about your Medical Practice' Risk Adjustment Documentation? Do you apply documentation guidelines for Avoiding RED flags in your practice...? Test yourself to see how much do you know about Risk Adjustment Documentation guidelines. Open the following link on your Desktop (instead of your phone). PROMOTE your Business for FREE for 14 Days by using Multiple Landing Pages... Try it: Free 14 Day Trial Pages Call Friends abroad. Smile and Talk With Plant Protein Complete, you are getting one of the most bio-available complete protein sources available. Click HERE Vitamin D t aken in conjunction with K2 allows the greatest bio-availability in the body. Click HERE For any issues due to your Bad Credit... Worried about your Loan Approval?.... Call 855-514-1501 or Click HERE
14 Category I codes for COVID-19 immunizations content media
0
0
51
broro75
Jan 21, 2021
In General Discussions
HCC coders.... do not have any power of diagnosis coding decision.They cannot apply a clinical interpretation to information within the record. Accurate diagnosis code assignment is dependent on the healthcare provider clearly describing each medical diagnosis to the higher level of specificity. To me, the only way they can influence the medical documentation is through Physician Query. What do you think? What else will you advise they should use? BC Advantage magazine did publish on this topic. Here is the link: https://www.billing-coding.com/detail_article.cfm?articleID=6327&email Go below to <<Get an answer>> for your comment. Be the first one receiving emails from us about our Services, quizzes, and Articles published on our Blog and Forum Click HERE KN95 PROTECTIVE FACE MASK (10) 3 PLY FACE MASK WITH EYE SHIELD (25 PACK) ALLI ORLISTAT 60 MG CAPSULES WEIGHT LOSS AID
Tell me one of the Best Strategies for HCC Coders and CDI Specialists...... content media
0
0
48
broro75
Dec 13, 2020
In General Discussions
The documentation in the medical record is essential for coding and reimbursement. It is also critical for caring for the patient. Healthcare providers often get focused on curing and healing and give less time for documenting. Going to the providers to get more information is an essential link. Medical coders can help providers realize things that they need to include in the documentation; it will help with reimbursement and help people get better. Hence the question: how can HCC coder influence medical documentation? Do you have the answer? Click on the <<answer>> button to share your thoughts and knowledge with us. Get your Gift online: KN95 Mask (FDA approved) Christmas Trees Perfume for women Online Education Laptop Plant Protein Complete
How can HCC coders influence medical documentation? content media
0
0
45
broro75
Nov 07, 2020
In General Discussions
We all know that medical coders do not have any power to make diagnosis decisions. They must apply a strictly literal interpretation to the healthcare provider’s medical record documentation. They are not allowed to make assumptions or presume to know the healthcare provider’s intent. But, there is always a <<but>>: Guideline I.A.15. I am still seeing so many medical coders missing the opportunity to code two conditions as related when they are linked by the word << with >> in the alphabetic index. Indeed, this Guideline empowers medical coders to make certain diagnosis coding decisions without having to query the provider. To read more about it, see the article published by AAPC by clicking the link: bit.ly/2mdkA4Q Diabetic Supplies 80 discount on Exercise and Fitness idem until 11/09/2020 Online Education Free Christmas (Noel) songs Phone Cards Online
Diagnosis Coding Decision content media
0
0
45
broro75
Oct 31, 2020
In General Discussions
HCC coders should carefully review the patients' health records with known conditions associated with Heart failure (CAD, Renal failure, Hyperthyroidism, MI, Heart valve disorder, Arrhythmia, Sarcoidosis) for any signs and symptoms. Look at the medication list. Are there any medications indicating a treatment of Chronic Heart Failure? Review the medication orders for any adjustment in P. O. medication dosage or the evidence of a P.O. medication being changed to an IV route. This may indicate an exacerbation of chronic Heart failure. Report decompensated Heart Failure as an Acute on chronic Heart Failure. Advanced structural Heart disease and symptoms with little or no physical exertion are the hallmarks of End-stage Heart failure. According to AHA's Coding Clinic, the ACC (American College Cardiology) and AHA (American Heart Association) classify Heart Failure in Stages, with End-Stage Heart failure falling into stage D. End-Stage Heart Failure also falls into class III or IV of the NYHA (New-York Heart Association) functional classification. It is determined by the limitations that heart failure puts on physical activity. About Stage B and Stage C heart failure, when you go to the index part of ICD-10-CM book 2021, you will see the following: · Stage B Heart Failure............... See also Failure, Heart, by type (I50.9) · Stage C Heart Failure............... See also Failure, Heart, by type (I50.9) Stage A heart failure is a risk of Heart failure, but it is not Heart Failure. Report Stage A Heart Failure with code Z91.89 (other specified personal Risk factors, not elsewhere classified), according to AHA's Coding Clinic. Never report Stage A Heart Failure with I50.9 Amazon Best Sellers Risk Adjustment Documentation and Coding E/M Office Visit Compendium 2021 Netter Atlas of Human Anatomy for CPT Coding, Third Edition Coding with Modifiers, 6th Edition Diabetic supplies Online Education Phone Cards Online
Heart Failure content media
0
0
90
broro75
Oct 28, 2020
In General Discussions
We always submit the code E11.51 every time we see both DM and PVD reported in the notes, even in the absence of the healthcare provider documentation explicitly linking them. It is the same scenario when a patient has both DM and Atherosclerosis of arteries of lower extremity where we report E11.51 and the subcategory I70.2 But what about DM and Calcification of Aorta? Some HCC coders don't think it is right to submit code E11.51 in this situation. Please share your thoughts with us. Is it OK or not? And why? Thank you in advance for taking the time to share info on this topic with us. Medical Record Auditor Risk Adjustment Documentation and Coding Coding with Modifiers ( 6th edition) Write a Kick Butt Contract for your Medical Billing Service Secrets to Signing up your First Doctor How to start your own Successful Medical Billing Business Pricing your Medical Billing Service Phone Cards Online For more Books, go to : https://www.lsfmraauditing.com/affiliate-shop-1
Diabetic peripheral angiopathy (E11.51)? content media
0
0
65
broro75
Oct 11, 2020
In General Discussions
Codes Effective April 1, 2020 .U07.0 Vaping-related disorder Use additional codes to identify manifestations .U07.1 COVID-19 Use additional codes to identify manifestations New codes: Elevated Liver Enzymes . R74.01 Elevation of levels of liver transaminase levels . R74.02 Elevation of levels of lactic acid dehydrogenase [LDH] New codes: Stage 3 Chronic Kidney Disease N18.30 Chronic kidney disease, stage 3 unspecified N18.31 Chronic kidney disease, stage 3a N18.32 Chronic kidney disease, stage 3b .Code assignment should be based on provider documentation of the stage. New Codes: C3 Glomerulonephritis New codes at categories N00 to N07 to identify C3 glomerulopathy: . N00.A Acute nephritic syndrome with C3 glomerulonephritis . N01.A Rapidly progressive nephritic syndrome with C3 glomerulonephritis . N02.A Recurrent and persistent hematuria with C3 glomerulonephritis . N03.A Chronic nephritic syndrome with C3 glomerulonephritis . N04.A Nephrotic syndrome with C3 glomerulonephritis . N05.A Unspecified nephritic syndrome with C3 glomerulonephritis . N06.A Isolated proteinuria with C3 glomerulonephritis . N07.A Hereditary nephropathy, not elsewhere classified with C3 Glomerulonephritis New Codes: Pulmonary Eosinophilic Diseases .J82.81 Chronic eosinophilic pneumonia .J82.82 Acute eosinophilic pneumonia .J82.83 Eosinophilic asthma .J82.89 Other pulmonary eosinophilia, not elsewhere Classified New Codes: Fibrotic Interstitial Lung Disease .J84.170 Interstitial lung disease with progressive fibrotic phenotype in diseases classified elsewhere .J41.78 Other interstitial pulmonary diseases with fibrosis in diseases classified elsewhere New Codes: Congenital Myopathies .G71.20 Congenital myopathy, unspecified .G71.21 Nemaline myopathy .G71.22 Centronuclear myopathy .G71.220 X-linked myotubular myopathy .G71.228 Other centronuclear myopathy .G71.29 Other congenital myopathy New Codes: Cerebrospinal Fluid Leak .G96.00 Cerebrospinal fluid leak, unspecified .G96.01 Cranial cerebrospinal fluid leak, spontaneous .G96.02 Spinal cerebrospinal fluid leak, spontaneous .G96.08 Other cranial cerebrospinal fluid leak .G96.09 Other spinal cerebrospinal fluid leak New Codes: Disorders of Meninges .G96.191 Perineural cyst .G96.198 Other disorders of meninges, not elsewhere classified New Codes: Intracranial Hypotension G96.81 Intracranial hypotension .G96.810 Intracranial hypotension, unspecified .G96.811 Intracranial hypotension, spontaneous .G96.819 Other intracranial hypotension .G97.83 Intracranial hypotension following lumbar cerebrospinal fluid shunting .G97.84 Intracranial hypotension following other procedure. New codes: Acquired Autoimmune Hemolytic Anemias . D59.10 Autoimmune hemolytic anemia, unspecified . D59.11 Warm autoimmune hemolytic anemia . D59.12 Cold autoimmune hemolytic anemia . D59.13 Mixed type autoimmune hemolytic anemia . D59.19 Other autoimmune hemolytic anemia New Codes: Eosinophil Diseases . D72.10 Eosinophilia, unspecified . D72.110 Idiopathic hypereosinophilic syndrome [IHES] . D72.111 Lymphocytic variant hypereosinophilic syndrome [LHES] . D72.118 Other hypereosinophilic syndrome . D72.119 Hypereosinophilic syndrome [HES], unspecified . D72.12 Drug rash with eosinophilia and systemic symptoms syndrome . D72.18 Eosinophilia in diseases classified elsewhere . D72.19 Other eosinophilia New Codes: Immunodeficiencies .D84.81 Immunodeficiency due to conditions classified elsewhere .D84.821 Immunodeficiency due to drugs .D84.822 Immunodeficiency due to external causes .D84.89 Other immunodeficiencies New Codes: Cytokine Release Syndrome . D89.831 Cytokine release syndrome, grade 1 . D89.832 Cytokine release syndrome, grade 2 . D89.833 Cytokine release syndrome, grade 3 . D89.834 Cytokine release syndrome, grade 4 . D89.835 Cytokine release syndrome, grade 5 . D89.839 Cytokine release syndrome, grade unspecified Specific grade should be assigned on the basis of explicit provider documentation of the grade; otherwise the code for unspecified grade should be assigned. New Codes: Sickle-Cell Disorders Sickle cell disorders with cerebral vascular involvement . D57.03 Hb-SS disease with cerebral vascular involvement . D57.213 Sickle-cell/Hb-C disease with cerebral vascular involvement . D57.413 Sickle-cell thalassemia, unspecified, with cerebral vascular involvement . D57.813 Other sickle-cell disorders with cerebral vascular Involvement Sickle cell disorders with crisis and other complications . D57.09 Hb-SS disease with crisis with other specified complication . D57.218 Sickle-cell/Hb-C disease with crisis with other specified complication . D57.418 Sickle-cell thalassemia, unspecified, with crisis with other specified complication . D57.818 Other sickle-cell disorders with crisis with other specified complication New Codes: Sickle Cell-Thalassemia Beta Zero (HbS-ß0) – . D57.42 Sickle-cell thalassemia beta zero without crisis . D57.431 Sickle-cell thalassemia beta zero with acute chest syndrome . D57.432 Sickle-cell thalassemia beta zero with splenic sequestration . D57.433 Sickle-cell thalassemia beta zero with cerebral vascular involvement . D57.438 Sickle-cell thalassemia beta zero with crisis with other specified complication . D57.439 Sickle-cell thalassemia beta zero with crisis, Unspecified New Codes: Sickle-Cell Sickle Cell-Thalassemia Beta Plus (HbS- ß+) – . D57.44 Sickle-cell thalassemia beta plus without crisis . D57.451 Sickle-cell thalassemia beta plus with acute chest syndrome . D57.452 Sickle-cell thalassemia beta plus with splenic sequestration . D57.453 Sickle-cell thalassemia beta plus with cerebral vascular involvement . D57.458 Sickle-cell thalassemia beta plus with crisis with other specified complication . D57.459 Sickle-cell thalassemia beta plus with crisis, Unspecified New Codes: Substance Use and Abuse with Withdrawal . F10.130 Alcohol abuse with withdrawal, uncomplicated . F10.131 Alcohol abuse with withdrawal delirium . F10.132 Alcohol abuse with withdrawal with perceptual disturbance . F10.139 Alcohol abuse with withdrawal, unspecified . F10.930 Alcohol use, unspecified with withdrawal, uncomplicated . F10.931 Alcohol use, unspecified with withdrawal delirium . F10.932 Alcohol use, unspecified with withdrawal with perceptual disturbance . F10.939 Alcohol use, unspecified with withdrawal, unspecified . F11.13 Opioid abuse with withdrawal . F12.13 Cannabis abuse with withdrawal . F13.130 Sedative, hypnotic or anxiolytic abuse with withdrawal, uncomplicated . F13.131 Sedative, hypnotic or anxiolytic abuse with withdrawal delirium . F13.132 Sedative, hypnotic or anxiolytic abuse with withdrawal with perceptual disturbance . F13.139 Sedative, hypnotic or anxiolytic abuse with withdrawal, unspecified . F14.13 Cocaine abuse, unspecified with withdrawal . F14.93 Cocaine use, unspecified with withdrawal . F15.13 Other stimulant abuse with withdrawal . F19.130 Other psychoactive substance abuse with withdrawal, uncomplicated . F19.131 Other psychoactive substance abuse with withdrawal delirium . F19.132 Other psychoactive substance abuse with withdrawal with perceptual disturbance . F19.139 Other psychoactive substance abuse with withdrawal, unspecified New Codes: Esophagitis .K20.80 Other esophagitis without bleeding .K20.81 Other esophagitis with bleeding .K20.90 Esophagitis, unspecified without bleeding .K20.91 Esophagitis, unspecified with bleeding .K21.00 Gastro-esophageal reflux disease with esophagitis, without bleeding .K21.01 Gastro-esophageal reflux disease with esophagitis, with bleeding New Codes: Hepatic Fibrosis .K74.00 Hepatic fibrosis, unspecified .K74.01 Hepatic fibrosis, early fibrosis .K74.02 Hepatic fibrosis, advanced fibrosis New Codes: Joint-Related Disorders Twenty-one new codes have been created for several joint related disorders by adding “other specified site” or “other specified joint”e.g., rheumatoid arthritis, osteoarthritis, dislocation New codes for temporomandibular joint disorders . M26.64 Arthritis of temporomandibular joint . M26.65 Arthropathy of temporomandibular joint . New codes specify laterality New Codes: Pathological Fractures Due to Osteoporosis .M80.0A Age-related osteoporosis with current pathological fracture, other site .M80.8A Other osteoporosis with current pathological fracture, other site Juvenile Osteochondrosis Tibia and Fibula Subcategory M92.5, Juvenile osteochondrosis of tibia and fibula, has been expanded to distinguish juvenile osteochondrosis (Blount’s Disease vs Osgood-Schlatter Disease) . Unspecified juvenile osteochondrosis (M92.50-) . Juvenile osteochondrosis of proximal tibia (M92.51-) . Juvenile osteochondrosis of tibia tubercle (M92.52-) . Other juvenile osteochondrosis of tibia and fibula (M92.59-) . Sixth characters at each of the codes identify laterality (i.e. unspecified leg, right leg, left leg and bilateral). New Codes: Granulomatous Mastitis .N61.20 Granulomatous mastitis, unspecified breast .N61.21 Granulomatous mastitis, right breast .N61.22 Granulomatous mastitis, left breast .N61.23 Granulomatous mastitis, bilateral breast New Codes: Cesarean Delivery Scars .O34.218 Maternal care for other type scar from previous cesarean delivery .O34.22 Maternal care for cesarean scar defect (isthmocele) New codes: Expansion of Code O99.89 to Identify Stage . O99.891 Other specified diseases and conditions complicating pregnancy . O99.892 Other specified diseases and conditions complicating childbirth . O99.893 Other specified diseases and conditions complicating puerperium New Codes: Neonatal Cerebral Infarction .P91.821 Neonatal cerebral infarction, right side of brain .P91.822 Neonatal cerebral infarction, left side of brain .P91.823 Neonatal cerebral infarction, bilateral .P91.829 Neonatal cerebral infarction, unspecified side New codes: Headache with Orthostatic Component . R51.0 Headache with orthostatic component, not elsewhere classified . R51.9 Headache, unspecified Also known as positional headache, postural headache or orthostatic headache. Superficial Injury of Thorax Category S20, Superficial injury of thorax, expanded and codes created to identify the middle and bilateral walls of the front thorax . Contusion (S20.2-) . Unspecified superficial injury (S20.30-) . Abrasion (S20.31-) . Blister (S20.32-) . External constriction (S20.34-) . Superficial foreign body (S20.35-) . Insect bite (S20.36-) . Other superficial bite (S20.37-) Results in 54 new codes. New codes: Synthetic Narcotics – Fentanyl . T40.41 Poisoning by, adverse effect of and underdosing of fentanyl or fentanyl analogs . T40.411 Poisoning by fentanyl or fentanyl analogs, accidental (unintentional) . T40.412 Poisoning by fentanyl or fentanyl analogs, intentional self-harm . T40.413 Poisoning by fentanyl or fentanyl analogs, assault . T40.414 Poisoning by fentanyl or fentanyl analogs, undetermined . T40.415 Adverse effect of fentanyl or fentanyl analogs . T40.416 Underdosing of fentanyl or fentanyl analogs New codes: Synthetic Narcotics – Tramadol . T40.42 Poisoning by, adverse effect of and underdosing of tramadol . T40.421 Poisoning by tramadol, accidental (unintentional) . T40.422 Poisoning by tramadol, intentional self-harm . T40.423 Poisoning by tramadol, assault . T40.424 Poisoning by tramadol, undetermined . T40.425 Adverse effect of tramadol . T40.426 Underdosing of tramadol New codes: Other Synthetic Narcotics . T40.49 Poisoning by, adverse effect of and underdosing of other synthetic narcotics . T40.491 Poisoning by other synthetic narcotics, accidental (unintentional) . T40.492 Poisoning by other synthetic narcotics, intentional self-harm . T40.493 Poisoning by other synthetic narcotics, assault . T40.494 Poisoning by other synthetic narcotics, undetermined . T40.495 Adverse effect of other synthetic narcotics . T40.496 Underdosing of other synthetic narcotics New codes: Adverse Incidents due to Therapeutic and Rehabilitative Ophthalmic Devices . Y77.11 Contact lens associated with adverse incidents . Y77.19 Other therapeutic (nonsurgical) and rehabilitative ophthalmic devices associated with adverse incidents New Codes: Electric Scooter and Other Micro- Mobility Devices . External cause of morbidity and mortality codes for Pedestrian Injured In Transport Accident (categories V00-V06) . Standing electric scooters (e-scooters) and other ultra-light standing micro-mobility devices . Results in 123 new diagnosis codes when including the 7th characters for initial encounter, subsequent encounter and sequelae. New codes: Z Code Update . Z03.82 Encounter for observation for suspected foreign body ruled out . Z03.821 Encounter for observation for suspected ingested foreign body ruled out . Z03.822 Encounter for observation for suspected aspirated (inhaled) foreign body ruled out . Z03.823 Encounter for observation for suspected inserted (injected) foreign body ruled out With the 490 new codes and the 47 revised codes, there is a lot to learn. Now it is time to get your own ICD-CM-10 book 2021. You need to know also about the Guideline changes. Get your ICD-10-CM book 2021 via our site at no additional cost for you (we are an Amazon Associate) https://www.lsfmraauditing.com/affiliate-shop-1 Once you get on the website, click on the book picture and buy your book. Thank you for your support. Phone Cards Online
The new codes in ICD-10-CM book content media
0
0
149
broro75
Oct 06, 2020
In General Discussions
Malnutrition develops when the body lacks the needed vitamins, minerals, and other nutrients to maintain healthy tissues and organ functions. As Risk Adjustment coders, we always look at the BMI to think about Malnutrition. But what other clinical indicators can drive us to query the healthcare provider about the presence of this condition? Please share with us your points of view. women perfume As an Amazon Associate, I earn from qualifying purchases at no additional cost for you. Phone Cards Online
What are the clinical indicators of Malnutrition? content media
0
1
140